The use of IMCIVREE in pediatric patients aged 2 to less than 6 years with weight less than 20 kg and severe renal impairment is not recommended [ see Dosage and Administration (2.4), Clinical Pharmacology (12.3)]
Support Beyond Prescriptions Support Beyond Prescriptions Education, communication, and continued guidance can make the overall experience significantly more valuable
Discussion In multi-omics studies, analyzing individual samples enables exploration of individual-level variability and supports robust statistical inference [24]
However, many patients report that eating smaller, protein-rich meals approximately 12 hours after injection feels more comfortable, as the medication's appetite-suppressing effect stabilizes
In addition, publication bias may have influenced the findings, as studies with positive results regarding TZP are more likely to appear in the scientific literature